| 标题 |
Talazoparib plus enzalutamide in men with HRR-deficient metastatic castration-resistant prostate cancer: final overall survival results from the randomised, placebo-controlled, phase 3 TALAPRO-2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Karim Fizazi; Arun Azad; Nobuaki Matsubara; Joan Carles; André P. Fay; et al 出版日期:2025-07-16 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)